Revista de Gastroenterología del Perú - Volumen 21, Nº1 2001


REFERÊNCIAS BIBLIOGRÁFICAS

1) Adams PC. Population screening for hemochromatosis. Hepatology 29:1324-7

2) Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996; 23:724-7.

3) Adams PC, Campion ML, Gandon G, et al. Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families. Hepatology 1997;26:986-90.

4) Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998;114:319-23.

5) Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemocrhomatosis. Hepatology 1997;25:162-6.

6) Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis. Decision analysis model based on a 30-year database. Gastroenterology 1995; 109:177-88.

7) Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-72.

8) Adams PC, Valberg LS. Evolving expression of hereditary hemochromatosis. Sem Liver Dis 1996;16:47-54.

9) Anand S, Schade RR, Bendetti C, et al. Idiopathic hemochromatosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband. Hepatology 1983; 3:714-8.

10) Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-95.

11) Bacon BR. Diagnosis and management of Hemochromatosis. Gastroenterology 1997;113:995-9.

12) Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic Steatohepatitis: An expanded clinical entity. Gastroenterology 1994;107:1103-9

13) Bacon B, Olynyk JK, Brumt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999;130:953-62

14) Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: At the crossroads. Gastroenterology 1999; 16:193-207.

15) Bacon BR, Schratz CL, Britton RS, Wolff RK. Presence of the hemochromatosis genotype in patients with liver disease. Gastroenterology 1997;112:A1218.

16) Balan V, Baldus W, Fairbanks V, et al. Screening for hemochromatosis: Cost-effectiveness study based on 12,258 patients. Gastroenterology 1994;107:453-9.

17) Barton JC, McDonnell SM, Adams PC, et al. Management of hemochromatosis. Ann Intern Med 1998;129:932-9.

18) Basset ML, Halliday JW, Ferris RA, Powell LD. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology 1984;87:628-33.

19) Basset ML, Halliday JW, Powell LD. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986 6:24-9.

20) Beutler E. Genetic irony beyong haemochromatosis: clinical effects of HLA-H mutations. Lancet 1997;349:296-7.

21) Bonkovsky HL. Therapy of hepatitis C: other options. Hepatology 1997; 26: 143S-150S

22) Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB. Iron in liver diseases other than hemochromatosis. Sem Liver Dis 1996;16:65-82.

23) Bonkovsky HL, Ponka P, Bacon BR, Drysdale J, Grace ND, Tavill AS. An update on iron metabolism: summary of the Fifth International Conference on disorders of iron metabolism. Hepatology 1996;24:718-729

24) Bonkovsky HL, Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology 1990;99:1079-91.

25) Brunt EM, Tavill AS, Bacon BR. A 49-year-old man with alpha-1-antitrypsin deficiency and abnormal iron study results. Sem Liver Dis 1996;16:97-101.

26) Bryan CF, Leech SH, Kumar P, et al.The immune system in hereditary hemochromatosis: A quantitative and functional assessment of the cellular arm. Am J Med Sci 1991; 301:55-61.

27) Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335:1799-805.

28) Chapman RW, Morgan MY, Boss AM, Sherlock S. Acute and chronic effects of alcohol on iron absorption. Dig Dis Sci 1983;28:321-7.

29) Crawford DHG, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation Gastroenterology 1998;114:1003-8.

30) Crosby WH. A history of phlebotomy therapy for hemochromatosis. Am J Med Sci 1991; 301:28-31.

31) Deugnier YM, Guyader D, Crantock L, et al. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 1993;104:228-34.

32) Deugnier YM, Loréal O, Turlin B, et al. Liver pathology in genetic hemochromasosis: A review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-9.

33) Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-13

34) Edwards CQ, Cartwright GE, Skolnick MH, Amos DB. Homozigosity for hemochromatosis: Clinical manifestations. Ann Intern Med 1980; 93:519-25.

35) Edwards CQ, Griffin LM, Goldgar D, et al. Prevalence of hemochromatosis among 11,065 presumably health blood donors. N Engl J Med 1988; 318:1355-62.

36) Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993;328:1616-20.

37) Fargion S, Fracanzani AL, Piperno A, et al. Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology 1994;20:1426-31.

38) Fargion S, Mandelli C, Piperno A, et al. Survival and prognostic factors in 212 patients with genetic hemochromatosis. Hepatology 1992;15:655-9.

39) Farrel FJ, Nguyen M, Woodley S, et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology 1994;20:404-10.

40) Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.

41) Feder JN, Tsuchiahshi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLH-H disrupts beta-2-microglobulin interaction and cell surface expression. J Biol Chem 1997;272:14025-8.

42) Fleming M, Trenor C, Su M, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997;16:383-6.

43) George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-8.

44) Guyader D, Gandon Y, Deugnier Y, et al. Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis. Gastroenterology 1989;97:737-43.

45) Guyader D, Jacquelinet C, Moirand R, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-36.

46) Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14:249-51.

REGRESAR AL ARTÍCULO